[Definition of priority medicines for monitoring laboratory quality in Brazil: the interface between health surveillance and the National Drug Policy].

Autor: Pontes Junior DM; Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil. durvalmp@yahoo.com.br, Pepe VL, Osorio-de-Castro CG, Massena EP, Portela MC, Miranda Mdo C, Silva RS

Publikováno v: Cadernos de saude publica [Cad Saude Publica] 2008 Sep; Vol. 24 (9), pp. 2081-90.